By 2027, the market size of botulinum toxin type A is expected to increase from US$5.8004 billion in 2020 to US$13.81 billion, with a compound annual growth rate of 13.2% from 2021 to 2027.

In its latest report, QY Research conducted a meticulous analysis of the global botulinum toxin type A market. All market forecasts provided in the report are true and reliable.
Botulinum toxin is a bacterial toxin secreted by the deadly botulinum toxin. It acts on cholinergic nerve endings, antagonizes calcium ions, interferes with the release of acetylcholine, prevents muscle fibers from contracting and causes muscle relaxation, achieving the purpose of wrinkle removal and beauty. As a biological weapon, it was later used by the medical profession to treat facial spasms and other muscle movement disorders. In the 1980s, the plastic surgery industry expanded its functions, using it to thin the face and shape the legs. China is the third country to produce its own botulinum beauty products after the United Kingdom and the United States, and started to use them in 1999. In recent years, the global type A botulinum toxin has developed rapidly, with an average growth rate of about 15%. In 2017, the global production of type A botulinum toxin was 22.35 million bottles, with an output value of 4 billion US dollars. Affected by the economic environment, the improvement of people’s health, and social and economic development, the price of type A botulinum toxin is on a downward trend. Low-end products flooded into the market, and the price dropped from US$194/bottle in 2013 to US$178/bottle in 2017. As domestic companies become bigger and stronger, and new products continue to emerge, we expect prices to continue to fall in the next few years. There are three main types of Botox products: 50 units, 100 units and others. Among them, 50 units accounted for the largest share, accounting for 59% of the market share in 2017. Cosmetic use. Medical uses account for the majority, accounting for about 51% of the total market in 2017. The United States is the largest sales region, accounting for 54% of global sales in 2017. In 2017, China accounted for 5% of global products China accounted for 9% of global sales. China is an importing country. North America is also a major consumption region, but due to the high level of development in these regions, the annual growth rate is relatively flat. At present, there are only two kinds of botulinum approved in China, the balance agent and the allergen protectant of the Lanzhou Institute of Biological Products, which have not changed in recent years. Muscle and itself, such as face-lifting and leg-lifting, are cheap in weight and cost-effective; but propofol has low dispersion and is suitable for precision injections such as wrinkle removal. At present, Allergan, Epson, Merz Pharmaceuticals, Medytox, Lanzhou Hengli and other industrial giants represented by products occupy the mainstream position in the international market. The major global players in Botox Type A include Allergan (AGN), Ipsen, Merz Pharmaceuticals, etc. The United States is the largest market with a share of about 75%, followed by China and Europe, both with a share of about 20%. From the product point of view, 50iu is the largest market segment, with a share of about 60%. In terms of application, the largest application is medical use, followed by cosmetic use. Market analysis and insight: The global botulinum type A market is expected to increase from USD 5.804 billion in 2020 to USD 13.81 billion by 2027, with a compound annual growth rate of 13.2 from 2021 to 2027. %.
* Main company profile. * Main business and competitor information * SWOT analysis and PESTEL analysis * Production, sales, revenue, price and gross margin * Market share and scale
Researched the major players in China’s botulinum type A market: Allergan (AGN), Ipsen, Merz Pharmaceuticals, Medytox, BTXA
The report provides a 6-year forecast (2021-2027) based on the growth of China’s Botox market in major regions such as the United States, Europe, Japan, China, India, Southeast Asia, South America, and South Africa. other.
Buy this report now ($3900): https://www.qyresearch.com/settlement/pre/0b07743210c466b63de3576437d8ca55,0,1,global-and-china-botulinum-toxin-a-market
1 Report overview 1.1 Research scope 1.2 By type 1.2.1 Global botulinum toxin market size growth rate by type: 2016 VS 2021 VS 2027 1.2.2 50iu 1.2.3 100iu 1.2.4 Other 1.3 Market by application 1.3.1 Global meat Toxin A market share (by application): 2016 VS 2021 VS 2027 1.3.2 Medical use 1.3.3 Cosmetic use 1.4 Research goals 1.5 year considerations 2 Global growth trends 2.1 Global botulinum toxin A market outlook (2016-2027 Year) 2.2 Growth trend of botulinum toxin A by region 2.2.1 Market scale of botulinum toxin A by region: 2016 VS 2021 VS 2027 2.2.2 Historical market share of botulinum toxin A by region (2016-2021) 2.2.3 Botulinum toxin market size by region (2022-2027) 2.3 Botulinum toxin industry dynamics 2.3.1 Botulinum toxin A market trends 2.3.2 Botulinum toxin A market drivers 2.3.3 Botulinum toxin Toxin A market challenge 2.3.4 Botulinum toxin A market constraints 3 Key competitive landscape Players3.1 The world’s highest-paid type A botulinum player 3.1.1 Global Top botulinum toxin player revenue (2016-2021) 3.1 .2 Global botulinum toxin revenue market share (2016-2021) 3.2 Global botulinum toxin A market share by company type (tier 1, tier 2, and tier 3) 3.3 Players covered: by revenue of botulinum toxin Rank 3.4 Global botulinum toxin A market concentration ratio 3.4.1 Global botulinum toxin market concentration ratio (CR5 and HHI) 3.4.2 20203.5 Top 10 global botulinum toxin revenues and top 5 companies Botulinum toxin A are mainly involved Headquarters and service areas 3.6 Key players Botulinum toxin A product solutions and services 3.7 Date of entry into the botulinum toxin market 3.8 Mergers and acquisitions, expansion plans 4 Botulinum toxin A breakdown data by type 4.1 Global by type Botulinum toxin A historical market size (2016-2021) 4.2 Global botulinum toxin A forecast market size by type (2022-2027) 5 Botulinum toxin A breakdown data by application 5.1 By application Segmented global botulinum toxin A historical market size (2016-2021) 5.2 liters obal botulinum toxin A application market size forecast (2022-2027) 6 North America 6.1 North American botulinum toxin market size (2016-2027) 6.2 Botox of North America Vegetarian A market size by type 6.2.1 North American botulinum toxin market size by type (2016-2021) 6.2.2 North American botulinum toxin market size by type (2022-2027) 6.2.3 by type North American botulinum toxin type A market size (2016-2027) 6.3 North American botulinum toxin type A market size by application 6.3.1 North American botulinum toxin market size by application (2016-2021) 6.3.2 by application North American botulinum toxin market size by application (2022-2027) 6.3.3 North American botulinum toxin market size by application (2016)-2027) 6.4 North American botulinum toxin type A market size by country/region 6.4.1 North American botulinum toxin type A market size by country/region (2016-2021) 6.4.2 North American botulinum toxin type A market size by country/region (2022-2027) 6.4.3 United States 6.4. 4 Canada 7 Europe 7.1 Market size of botulinum toxin A in Europe (2016-20 27) 7.2 Market size of botulinum toxin A in Europe by type 7.2.1 Market size of botulinum toxin A in Europe by type (2016 -2021) 7.2.2 European botulinum toxin A market size by type (2022-2027) 7.2.3 European botulinum toxin A market size by type (2016-2027) 7.3 by application Market size of botulinum type A in Europe 7.3.1 market size of botulinum type A in Europe by application (2016-2021) 7.3.2 market size of botulinum type A in Europe by application (2022-2027) 7.3. 3 European botulinum toxin market size by application (2016-2027) 7.4 European botulinum toxin market size by country/region 7.4.1 European botulinum toxin market size by country/region ( 2016-2021) 7.4.2 European botulinum toxin A market size by country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 United Kingdom 7.4.6 Italy 7.4.7 Russia 7.4.8 Northern Europe 8 Asia Pacific 8.1 Asia Pacific Botulinum toxin type A market size (2016-2027) 8.2 Asia-Pacific botulinum toxin A market size by type 8.2.1 Asia-Pacific botulinum toxin A market size by type (2016-2021) 8.2.2 Asia-Pacific Scale of botulinum toxin A logo by type (2022-2027) 8.2.3 Asia-Pacific botulinum toxin A market scale by type (2016-2027) 8.3 Asia-Pacific botulinum toxin A market size by application 8.3.1 Asia-Pacific botulinum toxin A market size by application (2016-2021) 8.3.2 Asia-Pacific botulinum toxin market size by application ( (2022-2027) 8.3.3 Asia-Pacific botulinum toxin market size by application (2016-2027) 8.4 Asia-Pacific botulinum toxin market size by region 8.4.1 Asia-Pacific botulinum toxin market size by region (2016-2021) 8.4.2 Asia-Pacific botulinum toxin market size by region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America Americas 9.1 Market size of botulinum toxin type A in Latin America (2016-2027) 9.2 Market size of botulinum toxin type A in Latin America 9.2.1 Market size of botulinum toxin type A in Latin America Market size by type (2016 -2021) 9.2.2 Latin America Botulinum Toxin Type A Market Size by Type (2022-2027) 9.2.3 Latin America Botulinum Toxin Type A Market Size by Ty (2016-2027) 9.3 Latin America A Market size of botulinum type A (by application) 9.3.1 Market size of botulinum type A in Latin America (2016-2021) 9.3.2 Market size of botulinum type A in Latin America (2022-2027) 9.3.3 By application Latin America Botox Type A Market Size (2016-2027) 9.4 Latin America Botox Type A Market Size by Country 9.4.1 Latin America Botox Type A Market Size by Country/Region ( 2016-2021) 9.4.2 Botox A toxin market size by country/region in Latin America (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East and Africa 10.1 Middle East and Africa Botox A market size (2016-2027) 10.2 The market size of botulinum toxin type A in the Middle East and Africa 10.2.1 The market size of botulinum toxin type A in the Middle East and Africa (2016-2021) 10.2.2 The market size of botulinum type A in the Middle East and Africa (2022-2027 ) 10.2.3 Middle East and Africa type A botulinum toxin market size by type (2016-2027) 10.3 Middle East and Africa type A botulinum toxin market size by application 10.3.1 Middle East and Africa A by application Market size of botulinum toxin type A (2016-2021) 10.3.2 Market size of botulinum toxin type A in the Middle East and Africa by application ( 2022-2027) 10.3.3 Middle East and Africa type A botulinum toxin market size by application (2016-2027) 10.4 Middle East and Africa type A botulinum toxin market size by country 10.4.1 Middle East and Africa type A meat Toxicbacteria market size (2016-2021) 10.4.2 Middle East and Africa type A botulinum market size Countries (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Introduction to major players 11.1 Allergan (AGN) 11.1.1 Allergan (AGN) Company Details 11.1.2 Allergan (AGN) Business Overview 11.1.3 Allergan (AGN) Botulinum Toxin A Introduction 11.1.4 Allergan (AGN) Meat Toxin business revenue (2016-2021) 11.1.5 Allergan (AGN) Recent Development 11.2 Ipsen 11.2.1 Ipsen Company Details 11.2.2 Ipsen Business Overview 11.2.3 Ipsen Type A Meat Toxin introduction 11.2.4 Ipsen A-type botulinum toxin business revenue (2016-2021) 11.2.5 Ipsen recent development 11.3 Merz Pharmaceuticals 11.3.1 Merz Pharmaceuticals company details 11.3.2 Merz Pharmaceuticals business overview 11.3.3 Merz Pharmaceuticals botulinum toxin A introduction 11.3.4 Merz Pharmaceuticals botulinum toxin A business revenue (2016-2021) 11.3.5 Merz Pharmaceuticals recent development 11.4 Medytox 11.4.1 Medytox company details 11.4.2 Medytox business overview 11.4.3 Medytox Botulinum toxin A introduction 11.4.4 Medytox botulinum toxin A business revenue (2016-2021) 11.4.5 Recent development B botulinum toxin 11.15 Medytox .1 BTXA company details 11.5.2 BTXA business overview 11.5.3 BTXA A Botulinum toxin type introduction 11.5.4 BTXA type A botulinum toxin business revenue (2016-2021) 11.5.5 BTXA recent development 12 Analyst opinion/conclusion Appendix 13.13 Methodology 13.1.1 Methodology/research method 13.1.2 Data sources 13.2 Disclaimer 13.3 Author details


Post time: Jul-05-2021